In a recent randomized, multicenter trial, results showed that the percentage of time that blood glucose remained within the target glycemic range (notwithstanding automated insulin delivery systems) was persistently suboptimal in patients with T1DM [10]. The gene discussed is INS; the disease is type 1 diabetes mellitus.